Aug 16 2007, 1:46 PM EST
News source: Business Wire
DomaniCell, LLC (DomaniCell), the leading service provider in the field of cell collection, processing, storage and therapies, is now expanding its service to the collection and storage of stem cells and immune system cells for adults who choose to proactively store their cells, while they are healthy and younger, for potential future use.
Collecting and banking one's stem cells and immune system cells is an increasingly important part of a proactive wellness plan. Such a plan is intended to take advantage of the growing number of regenerative and therapeutic treatments currently available and in development that utilize stem cells and cells of the immune system.
When collected and stored from younger and healthier donors, stem cells and immune system cells are more effective than those collected later in life or from a donor suffering from an illness or genetic disorder. Additionally, autologous (self) stem cell and immune system cell replacement has been demonstrated to be highly effective in restoring normal function after exposure to toxins, including radiation.
DomaniCell is part of Progenitor Cell Therapy LLC, a cell therapy development, manufacturing and distribution services company that has been serving the biotech sector since 1998 and has unparalleled experience with all types of cell therapeutic products on the market and in clinical development. Together the companies and their senior management team have performed over 30,000 cell therapy procedures, processed and stored over 18,000 cell therapy products and transported over 14,000 cell therapy products for clinical use in over 5000 patients to-date.
"DomaniCell and Progenitor Cell Therapy together provide an unmatched depth and breadth of experience in the collection, manufacturing, storage and delivery of human cells for clinical use," states Chairman Andrew L. Pecora, MD. "Our group of companies has provided cell therapy manufacturing, storage and delivery services for more patients treated with a cell therapy product than any company in the world. We have developed expertise in over 20 different types of cell-based therapeutics including cell-based therapies for brain and spinal cord repair, cardiovascular disease, diabetes and cancer and other regenerative medicines."
The companies' processing, manufacturing and storage operations are overseen by Dr. Robert A. Preti, President and Chief Scientific Officer of Progenitor Cell Therapy. Dr. Preti is one of the country's leading authorities on cell engineering, has been an active board member of the International Society for Cellular Therapy (ISCT), and has authored numerous papers in the field of cell and tissue processing, cell production and clinical research. He serves as an inspector for the Foundation for Accreditation of Cellular Therapy (FACT) and has served on a number of professional, state and federal regulatory committees charged with the development of accreditation, regulation, and licensure for cellular therapy manufacturing operations.
Also critical to DomaniCell's expertise and offering is unparalleled experience in the apheresis collection of immune system and stem cells under the direction of Dr. Michele Donato, DomaniCell's medical director. Dr. Donato, a recognized clinician and researcher in stem cell transplantation for the past 10 years, joined The Cancer Center at Hackensack University Medical Center after completing her fellowship in medical oncology at the renowned M.D. Anderson Cancer Center at the University of Texas, home of the largest stem cell transplantation program in the world. Dr. Donato is a member of the Foundation for the Accreditation of Cellular Therapy's Standard Oversight Committee and Collection Standards Subcommittee.
"Just as significant," Dr. Pecora continues, "is our approach to stem cell and immune system cell processing and storage. Our company offers the highest industry stand
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
News
Articles
Blogs